Human fibronectin extra domain B as a biomarker for targeted therapy in cancer

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)1555-1568
Number of pages14
JournalMolecular oncology
Volume14
Issue number7
DOIs
Publication statusPublished - Jul 2020

Keywords

  • angiogenesis
  • biomarker
  • cancer
  • extra domain B
  • immunotherapy
  • targeted therapy
  • FUSION PROTEIN L19-TNF
  • IMMUNOCYTOKINE L19-IL2
  • PROSTATE-CANCER
  • CELLULAR FIBRONECTIN
  • RECOMBINANT ANTIBODY
  • METASTATIC MELANOMA
  • RISK-STRATIFICATION
  • TUMOR VASCULATURE
  • INTERFERON-GAMMA
  • TISSUE FACTOR

Cite this